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Red or black ginseng has been reported more powerful than white/fresh ginseng in
dealing with various diseases/conditions including obesity. The major reason is that
heating/steaming, the process of making red or black ginseng, produces large amount
of bioactive compounds including ginsenoside Rg3 (Rg3), which are trace in fresh
or white ginseng. In the present study, Rg3 was applied both in pre-adipocytes and
obese mice to investigate the anti-adipogenic effects and relevant mechanisms. Our
results show that Rg3 dose-dependently inhibited cell differentiation both in 3T3L1 cells (30, 50, and 100 µM) and human primary pre-adipocytes (10, 20, and
30 µM). This inhibitory effect is accompanied by the attenuation of the expressions
of adipogenic markers including peroxisome proliferator-activated receptor gamma
(PPAR-γ), CCAAT/enhancer binding protein alpha (C/EBP-α), fatty acid synthase (FAS),
fatty acid binding protein 4 (FABP4) and perilipin. Although dietary intake of Rg3 (0.1 mg
Rg3/kg diet, 8 weeks) did not significantly affect body weight gain, fat pads and
food intake as well as of PPAR-γ expression in fat tissues, we found that hepatic
PPAR-γ and C/EBP-α protein expressions and hepatic glutathione reductase and
glutathione S-transferase, two major antioxidants molecules were significantly reduced
by Rg3. These results suggest that ginsenoside Rg3 may be a potential agent in
reducing/preventing obesity.
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Adipogenesis, the process of adipocytes differentiated from pre-adipocytes, plays a key role in the
adult obesity development because obese subjects have more fat cells compared to the lean subjects
(van Harmelen et al., 2003). Moreover, approximately 10% of fat cells turnover annually in both
lean and obesity adults, but obese adults recruited more adipocytes than lean adult (Spalding
et al., 2008). This is further supported by that adipocyte number is increased in response to a
high-fat diet in adult rats (Faust et al., 1978). The adipogenesis and lipogenesis (the process of
fatty acid, triglyceride synthesis, and fat drop packaging) are regulated by transcriptional cascades
PPAR-γ and CCAAT/enhancer binding proteins (C/EBPs), which are accompanied by a dramatic
Abbreviations: C/EBP-α, CCAAT/enhancer binding protein alpha; FAS, fatty acid synthase; FABP4, fatty acid binding
protein 4; GR, glutathione reductase; GST, glutathione S-transferase; HPAs, human primary adipocytes; IBMX, 3-isobutyl1-methylxanthine; MDI medium, IBMX + dexamethasone + insulin medium; PBS, phosphate-buffered saline; PCR,
polymerase chain reaction; PPAR-γ, peroxisome proliferator-activated receptor gamma.

Frontiers in Pharmacology | www.frontiersin.org

1

March 2017 | Volume 8 | Article 113

Zhang et al.

Ginseng and Obesity

and SuperSignal West Dura Extended Duration Substrate kit
were purchased from ThermoFisher Scientific (Rockford, IL,
USA). Mammalian protein extraction buffer were purchased
from GE Healthcare Bio-Sciences (Piscataway, NJ, USA).
Specific antibodies that recognized the PPAR-γ, C/EBP-α,
FAS, FABP4, Perilipin, β-actin were purchased from Cell
Signaling Technology (Danvers, MA, USA). Insulin from
Roche (Mannheim, Germany), and IBMX, dexamethasone, and
rosiglitazone from Sigma (St Louis, MO, USA) were used to
induce adipocyte differentiation. Ten percent buffered formalin
phosphate and 2-propanol were purchased from Fisher Scientific
(Fair Lawn, NJ, USA). Oil-red O solution was purchased
from Electron Microscopy Science (Hatfield, PA, USA). TACS
MTT cell proliferation assay kit was purchased from Trevigen
(Gaithersburg, MD, USA). Dimethyl sulfoxide (DMSO) was
purchased from Sigma (St Louis, MO, USA). RNeasy Mini Kit
was purchased from Qiagen (Valencia, CA, USA) and iTaq
Universal SYBR Green One-Step Kit was purchased from BioRad (Hercules, CA, USA). Ginsenoside Rg3 was purchased from
ChromaDex (Irvine, CA, USA) and was dissolved in DMSO,
aliquots at 100 mM was storage in −20◦ C freezer.

changes of expressions of FAS, FABP4, perilipin, adiponectin, and
perilipin (Gregoire et al., 1998). Adipogenic induction rapidly
induces expressions of C/EBP-β and C/EBP-δ at early clonal
expansion and growth arrest. Increased C/EBP-β and C/EBPδ target downstream key adipogenic transcriptional regulators
C/EBP-α, PPAR-γ and the regulator of lipogenic genes sterolregulatory-element-binding protein 1. PPAR-γ activates the
promoter of the genes encoding C/EBP-α and vice versa, creating
a positive-feedback loop. Increased C/EBP-α and PPAR-γ induce
the expression of genes that are involved in insulin sensitivity,
lipogenesis, and lipolysis, including those encoding glucose
transporter, FABP4, lipoprotein lipase, perilipin and the secreted
factors adiponectin and leptin (Lowe et al., 2011).
Ginseng has long history dealing with human health, and
various health benefits of ginseng have been reported on
cardiovascular disease (CVD) (Kim, 2012; Lee and Kim, 2014),
type 2 diabetes (T2D) (Jeon et al., 2013), immune function (Lui
et al., 2013; Jia et al., 2014), erectile dysfunction (Low and Tan,
2007; Jang et al., 2011; Choi et al., 2013), neural function (Liao
et al., 2002; Zheng et al., 2011; Ong et al., 2015), and obesity
(Yun et al., 2004; Kim et al., 2009). Although ginseng contains
varieties of bioactive compounds such as ginseng saponins,
peptides, polysaccharide, fatty acids, vitamins, alkaloids, lignans,
and flavonoids (Wang et al., 2012), Saponins, are named as
ginsenosides in 1957 by Brekhamn, are the major contributors
of the ginseng beneficial effects (Shibata et al., 1963; Cho et al.,
2013). Over 100 ginsenosides have been identified since the first
description in the 1960s (Shin et al., 2015). Ginsenoside Rg3
(Rg3) is trace naturally occurring in fresh and white ginseng,
but majorly comes from the heat processing of protopanaxadiol
(PPD) ginsenosides, such as Rb1, Rb2, Rc, and Rd from red
ginseng. Rg3 has been reported in inhibiting breast cancer
cell proliferation (Wang et al., 2008) and Alzheimer’s amyloid
beta peptide in mice (Chen et al., 2006) as well as vascular
inflammation in cells and animals (Cho et al., 2014). While
only one study reported the anti-obesity effect of Rg3 in 3T3L1 cells (Hwang et al., 2009), studies in primary human cells,
animals, and humans are still lacking. In the present study, Rg3
were treated in 3T3-L1 cells, human primary pre-adipocytes
(HPAs), and obese mice. We found that Rg3 dose-dependently
inhibited cell differentiation both in 3T3-L1 cells and HPAs,
which was accompanied by the reductions of proteins and mRNA
expressions of PPAR-γ, C/EBP-α, FAS, and FABP4. Rg3 also
reduced hepatic PPAR-γ and C/EBP-α protein expressions in
obese mice. The changes of these key molecules of adipogenesis
provide critical clues for us to understand how Rg3 inhibits fat
development in molecular level.

3T3-L1 Cell Culture
3T3-L1 cells were purchased from the American Type Culture
Collection (ATCC, Manassas, VA, USA). Passages between 5
and 25 were used in all experiments. The cells were cultured in
DMEM containing 10% fatal bovine serum and 1% penicillin
streptomycin mixture in an incubator with 5% CO2 at 37◦ C.

Human Primary Pre-adipocytes Cell
Culture
Human primary pre-adipocytes were purchased from ATCC
(Manassas, VA, USA). Cells were maintained at 37◦ C and 5%
CO2 in Fibroblast Basal Medium plus Fibroblast Growth Kit–
Serum-Free (ATCC, KS-201-040, purchased from ATCC) with
biotin (33 µM) and pantothenate (17 µM). Passages between 3
and 6 were used in all experiments.

Pre-adipocyte Differentiation

MATERIALS AND METHODS

3T3-L1 or HPAs were plated in 12-well plates, and adipocytes
differentiation was induced with a hormone cocktail containing
0.5 mM IBMX, 1 µM dexamethasone, 1 µM rosiglitazone,
and 10 µg/mL insulin (MDI, at day 0). After 3 days, the
medium was changed to normal medium containing 10 µg/mL
insulin. 3T3-L1 cells need 7 days and HPAs need 10 days to
accomplish the differentiation process. Both cells were treated
with indicated stimuli during the whole differentiation process
from Days 0 to 7 or Day 10 as previously described (Zebisch et al.,
2012).

Reagents

MTT Assay

Dulbecco’s modified Eagle’s medium from Gibco (Grand Island,
NY, USA) was used for culture. Fetal Bovine Serum from
Mediatech (Manassas, VA, USA) and penicillin streptomycin
from Gibco (Carlsbad, CA, USA) were used for enhancing
and maintaining the cell culture. Pierce BCA protein assay kit

Cells were cultured in 12-well plates with different dosages of Rg3
from 30 to 300 µM. Treated cells were incubated with 100 µl
MTT reagent per well for 4 h till purple dye was visible. Five
hundred microliter of detergent reagent was added into each
well and incubated in the dark for 4 h. The relative cell viability
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RNA temples were used for each treatment. The reaction
and cycling conditions for one-step real time PCR are: cDNA
synthesis 10 min at 50◦ C; reverse transcriptase inactivation 5 min
at 95◦ C; 45 cycles for PCR and detection, 10 s at 95◦ C, 30 s at
60◦ C. Designed primers PPAR-γ forward: TCG CTG ATG CAC
TGC CTA TG, PPAR-γ reverse: GAG AGG TCC ACA GAG CTG
ATT (Chen et al., 2013); β-actin forward: AGC CTT CCT TCT
TGG GTA TGG, β-actin reverse: CAC TTG CGG TGC ACG
ATG GAG (Bae C.R. et al., 2014) were used for the real time PCR
by using iTaq Universal SYBR Green One-Step Kit. Relative gene
expression was normalized by the expression of β-actin, and was
calculated by using 2−11Ct method.

was determined by the absorbance at 570 nm using Synergy H1
hybrid reader (BioTek Instruments, Inc., Winooski, VT, USA).

Oil-Red O Staining
After cells accomplished the differentiation process, cells were
fixed with 10% buffered formalin phosphate for 1 h at 4◦ C.
The cells were stained with Oil-red O dye. Fat droplets in
the adipocytes were stained with red color. The dye was then
dissolved in 100% isopropanol and relative fat accumulation was
measured by absorbance at 490 nm using Synergy H1 hybrid
reader (BioTek Instruments, Inc., Winooski, VT, USA).

Animal Feeding and Tissue Collection
Four week-old male obese leptin-deficient mice (B6.Cg-Lepob /J,
ob/ob), Jackson Laboratory (Bar Harbor, ME, USA) were feed
either with AIN-93G mineral mix standard food (0.88 kcal/g),
or standard food containing 0.01% ginsenoside Rg3 (0.1 mg
Rg3/kg diet, w/w) for 8 weeks. Body weight and food intake
were recorded weekly throughout the study. After 8-week
treatment, mice were euthanized with CO2 . All experimental
procedures were approved by the Institutional Animal Care and
Use Committee at Tennessee State University in accordance with
the National Institutes of Health Guidelines for the Care and
Use of Laboratory Animals. Blood, fat tissue, liver was harvested
and prepared for blood glucose, antioxidant activity, and relevant
proteins analysis.

Statistical Analysis
Data are presented as mean ± SEM of at least three independent
experiments performed in triplicate. Values of p < 0.05 were
considered to be significant.

RESULTS
Ginsenoside Rg3 Dose-Dependently
Inhibits Cell Differentiation in 3T3-L1
Cells
Ginsenoside Rg3 at 10, 30, 50 or 100 µM was added in
the medium from day 0 (adding differential inducer MDI
mixture) in 3T3-L1 cells. Various treatments were added to
new medium on days 3, 5, and 7 to replace medium in cells.
On day 10, cells were stained by Oil-red O to take images
and measure fat accumulation. Accumulated fat droplets were
dissolved in 100% isopropanol, and the intensity was measured
using a Synergy H1 microplate reader. As shown in Figure 1A,
Rg3 dose-dependently inhibited MDI-induced intracellular lipid
droplets, particularly at 100 µM, Rg3 almost abolished the
MDI effect. To make sure the anti-adipogenic effect of Rg3 is
not because of killing cells, we conducted a MTT cell viability
assay. We found that all concentrations (10–100 µM) of Rg3
having anti-adipogenic effect slightly increased cell proliferation
(Figure 1B). These results indicated that Rg3 prevented preadipocytes differentiation in 3T3-L1 cells in a dose-dependent
manner.

Protein Extraction and Western Blotting
Treated cells were washed once with PBS, and scraped into
mammalian protein extraction buffer. Cells were homogenized
by sonication on ice and centrifuged 10 min at 12,000 × g
at 4◦ C. Animal tissue was mixed with mammalian protein
extraction buffer and homogenized on ice. The supernatant
was collected as protein sample after centrifuging 10 min at
12,000 × g. Protein concentration was measured by Pierce BCA
protein assay kit. Protein sample was mixed with Laemmli
sample buffer and heated at 95◦ C for 5 min, and subjected
to western blot analysis. Samples were separated by 10% SDSPAGE and the membrane was blocked for 1 h with PBS (TBST)
containing 5% skim milk at room temperature. After washing
three times with TBST, the membrane was incubated with
relevant primary antibody at 4◦ C for overnight. The membrane
was washed three times with TBST and then incubated with
secondary antibody for 1 h at room temperature. Specific bands
were detected by SuperSignal West Dura chemiluminescence
(ThermoFisher Scientific, USA) and visualization was performed
by exposure of the membranes to X-ray films. The same set
of samples to detect different proteins. The same membrane
was stripped using a stripping buffer for 30 min, and blocked
and probed with a new primary antibody to detect the
next specific protein. Band intensities were quantified by
ImageJ software (National health institute, USA) (Lee et al.,
2013).

Ginsenoside Rg3 Dose-Dependently
Suppresses Protein Expressions of
PPAR-γ and C/EBP-α in 3T3-L1 Cells
Because of the key roles of PPAR-γ and C/EBP-α in adipogenesis,
we checked whether the Rg3 anti-adipogenic effect was
companied by change of PPAR-γ and C/EBP-α protein
expressions by Western blot. We found that MDI-induced PPARγ (Figure 2A) and C/EBP-α (Figure 2B) protein expressions were
dose-dependently reduced by Rg3 in 3T3-L1 cells, a very similar
pattern of the inhibitory effect of Rg3 in fat accumulation. PPARγ (Figure 2A) and C/EBP-α (Figure 2B) protein expression was
significantly reduced to 61% (p < 0.05) and 57% (p < 0.05) of
DMSO control, respectively, by Rg3 at 50 µM.

Quantitative Real Time PCR
Treated cells were used to isolate total RNA using RNeasy Mini
Kit instructed by the manufacturer’s protocol. Thirty nanograms
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FIGURE 1 | Ginsenoside Rg3 dose-dependently inhibits cell differentiation in 3T3-L1 cells. The cells stained with Oil-red O were dissolved in isopropanol
and relative fat accumulation was measured by absorbance using Synergy H1 hybrid reader at 490 nm. Oil-Red O representative images of lipid accumulation and
the average bar graph were shown (A, 40× magnification). Cell toxicity study was measure by a MTT assay (B). Changes by treatment were expressed as the
percentage of dimethyl sulfoxide (DMSO) control. Data are expressed as mean ± SE, n = 4. ∗ P < 0.05, ∗∗ P < 0.01 vs. DMSO control.

protein for fatty acids), and perilipin (a protein that coats lipid
droplets in adipocytes) are major makers of lipogenesis and fat
drop packing. We measured the protein expressions of these
proteins in 3T3-L1cells treated by various levels of Rg3. Rg3 dosedependently inhibited the protein expressions of FAS (Figure 4A)
and perilipin (Figure 4B), the same pattern of Rg3 on fat
accumulation, PPAR-γ and C/EBP-α expressions in 3T3-L1 cells.

Ginsenoside Rg3 Reduces PPAR-γ
mRNA Expression in 3T3-L1 Cells
To investigate whether Rg3 inhibits PPAR-γ protein level via
a transcriptional mechanism, we measured PPAR-γ mRNA
expression in 3T3-L1 cells using quantitative real time PCR.
Exposure of 3T3-L1 cells to various concentrations of Rg3 for
10 days, the same duration used to study the fat accumulation
and PPAR-γ protein expression, Rg3 dose-dependently inhibited
MDI-increased PPAR-γ mRNA expression, particularly reduced
to 20% of MDSO control at 50 µM (Figure 3). This is very
consistent with its effects on fat accumulation and PPARγ protein expression, suggesting that Rg3 inhibits PPAR-γ
expression at the transcriptional level.

Ginsenoside Rg3 Dose-Dependently
Reverses Lipid Accumulation, Protein
Expressions of Differentiation Markers in
HPAs
3T3-L1 cells are rodent cell lines, and concentrations of antiadipogenic effects of Rg3 are high (30–100 µM), which are not
realistic to get through dietary intake of ginseng or ginsenoside
Rg3. We would like to know whether HPAs are more sensitive
than 3T3-L1 cells in the anti-adipogenic effect of Rg3. Indeed,
comparing to the required Rg3 concentrations (30–100 µM)
in 3T3-L1 cells, Rg3 inhibited differentiation at much lower

Ginsenoside Rg3 Dose-Dependently
Attenuates Protein Expressions of Fat
Packing Proteins in 3T3-L1 Cells
Fatty acid synthase (An enzyme to catalyze the synthesis of
palmitate from acetyl-CoA and malonyl-CoA), FABP4 (A carrier
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FIGURE 2 | Ginsenoside Rg3 dose-dependently suppresses protein expressions of PPAR-γ (A) and C/EBP-α (B) in 3T3-L1 cells. On day 10, cells treated
with various concentrations of Rg3 were collected to measure PPAR-γ and C/EBP-α protein expressions by western blotting and normalized by β-actin expression.
The same membrane was stripped using a stripping buffer and blocked and probed with a new primary antibody to detect the next specific protein. Changes by
treatment were expressed as the percentage of DMSO control. Data are expressed as mean ± SE, n = 3. A set of representative images and bar graph were shown.
∗ P < 0.05, ∗∗ P < 0.01 vs. DMSO control.

C/EBP-α expressions and thereby prevents obesity in ob/ob
obese mice, a widely used obese animal model. We found that
dietary intake of Rg3 (0.1 mg Rg3/kg diet, 8 weeks) significantly
reduced PPAR-γ (Figure 6A) and C/EBP-α (Figure 6B) protein
expression in liver, the major organ of adipogenesis, although
we did not found significant change of PPAR-γ expression in
fat tissues. As shown in Table 1, we did not observe significant
changes in body weight and food intake by Rg3, however, the
fasting glucose was reduced by Rg3 (P = 0.091) at the end of
the experiment. In addition, we found that hepatic GR and GST,
two major antioxidants molecules, were significant decreased in
Rg3 group. These results are similar with previous study that the
obese-increased hepatic GR and GST were reversed by dietary
intake of grape seed extract in obese rats (Fernandez-Iglesias
et al., 2014).

FIGURE 3 | Ginsenoside Rg3 reduces PPAR-γ mRNA expression in
3T3-L1 cells. On day 10, cells treated with various concentrations of Rg3
were collected to measure PPAR-γ mRNA expression by quantitative real time
PCR and normalized by β-actin expression. The same membrane was
stripped using a stripping buffer and blocked and probed with a new primary
antibody to detect the next specific protein. Changes by treatment were
expressed as the percentage of DMSO control. Data are expressed as
mean ± SE, n = 3. ∗ P < 0.05, ∗∗ P < 0.01 vs. DMSO control.

DISCUSSION
In the present study, we reported for the first time that
ginsenoside Rg3 inhibited pre-adipocyte differentiation in HPAs
at much lower concentrations compared to the concentrations
worked in rodent pre-adipocytes 3T3-L1 cells. We are also
the first reporter that dietary supplementation Rg3 attenuated
hepatic protein expression of PPAR-γ, a key regulator of
adipogenesis and fat metabolism, as well as the improvements in
fasting blood glucose and hepatic antioxidants GR and GST in
obese mice. We also found that Rg3 dose-dependently inhibited
fat accumulation, expressions of PPAR-γ, C/EBP-α, FAS, and
perilipin in 3T3-L1 cells. These results suggest that ginsenoside
Rg3 may be a potential agent in reducing/preventing obesity.
Ginsenoside Rg3 naturally occurs at very low level in
American ginseng root extract (0.06%) (Wang et al., 2008)
and berry (0.03 mg/g) (Xie et al., 2007), but not detectable
(Kim et al., 2013) or trace (Kim et al., 2016) in Asian ginseng.

concentrations (10–30 µM) in HPAs (Figure 5A). Moreover,
Rg3 dose-dependently reduced DMI-increased proteins
expressions of PPAR-γ (Figure 5B), C/EBP-α (Figure 5C),
FABP4 (Figure 5D), and FAS (Figure 5E), the same pattern of
Rg3 on fat accumulation in HPAs. These results suggest that Rg3
exerts anti-adipogenic effect in HPAs with similar mechanisms
in 3T3-L1 cells, but needs much lower levels.

In vivo Effects of Ginsenoside Rg3
To confirm the anti-adipogenic effect of Rg3 in vivo, we tested
whether dietary supplementation of Rg3 inhibits PPAR-γ and
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FIGURE 4 | Ginsenoside Rg3 dose-dependently attenuates protein expressions of fat packing proteins FAS (A) and perilipin (B) in 3T3-L1 cells. On day
10, cells treated with various concentrations of Rg3 were collected to measure FAS and perilipin protein expressions by western blotting and normalized by β-actin
expression. The same membrane was stripped using a stripping buffer and blocked and probed with a new primary antibody to detect the next specific protein.
Changes by treatments were expressed as the percentage of DMSO control. Data are expressed as mean ± SE, n = 3. A set of representative images and bar
graph were shown. ∗ P < 0.05, ∗∗ P < 0.01 vs. DMSO control.

et al., 2015), which may be an alternative approach to replace the
traditional method of extracting these rare ginsenosides Rg3 and
Rh2 from Panax plants.
High hydrostatic pressure extract fresh ginseng and water
extract of red ginseng inhibit fat accumulation in 3T3-L1 cells
(Lee et al., 2015). Individual Rg3 (20–40 µM) has been reported
in attenuating differentiation in 3T3-L1 cells companied by
regulating AMPK and PPAR-γ signaling pathways (Hwang et al.,
2009). Our results are in line with these studies that Rg3 dosedependently (30–100 µM) inhibited 3T3-L1 cells differentiation,
attenuated expressions of critical markers of PPAR-γ, C/EBP-α,
FAS, and perilipin. Moreover, Rh2, one of the major metabolite
in the blood circulation after oral intake of Rg3 in rats (Fan
et al., 2016), dose-dependently (at 20 and 40 µM) decreased fat
accumulation in 3T3-L1 cells (Hwang et al., 2007). Similarly,
Rg5 and Rk1, degraded from Rg3 by dehydration at the C-20
position (Lee et al., 2009), also can reduce lipid accumulation
in 3T3-L1 cells although they are less effective than Rg3
(Kim et al., 2009). In addition, Rg3 at concentrations of 1–10 µM
significantly increased glucose uptake and expressions of glucose
transporter 4 (GLUT4), insulin receptor substrate (IRS-1), and
phosphatidylinositol 3-kinase (PI3K)-110α protein in 3T3-L1
cells (Lee O.H. et al., 2011). These results suggest that Rg3 and
its metabolites Rh2, Rg5, and Rk1 may be potential agents in
reducing adipogenesis.
3T3-L1 cells are widely used to study pre-adipocyte
differentiation because this cell line provides a homogeneous
population with virtually all cells being at the same stage.
However, 3T3-L1 pre-adipocytes are embryonal in origin,
are aneuploid and undergo early clonal expansion during
differentiation in culture (Cornelius et al., 1994). HPAs,
including both pre-adipocytes and fibroblast-like cells isolated
from human adults, are diploid, and differentiate in culture

However, heating/steaming, the traditional method in processing
red ginseng (steaming fresh ginseng at 95–100◦ C for a reasonable
time) and black ginseng (nine-time repetitive steaming white
ginseng at 95–100◦ C for 3 h) (Gui and Ryu, 2014), dramatically
increased Rg3 content both in Asian ginseng and American
ginseng. For instance, 2 h steaming increased Rg3 from 0.06 to
5.9% in American root (Wang et al., 2008). While Rg3 is low in
white Asian ginseng (0.004%), Rg3 (20S), and Rg3 (20R) can be
2.797 and 0.610%, respectively, in red Asian ginseng (Kim et al.,
2016). Moreover, Rg3 level in black Asian ginseng can be 3–10
times of the level in red Asian ginseng (Jo et al., 2012; Lee S.A.
et al., 2012). Using microwave and vinegar for 1 min increased
Rg3 from undetectable to 1.13% in the Korean ginseng berry
(Kim et al., 2013). In American ginseng, root (10.6 ± 0.4 mg/g)
contains higher Rg3 than that from leaf (7.5 ± 0.9 mg/g)
(Popovich and Kitts, 2004). In fact, Rg3 is mostly produced from
PPD ginsenosides, such as Rb1, Rb2, Rc, and Rd by attacking the
C-20 glycosidic bond through acid treatment or heat processing,
and the optimum condition producing ginsenoside Rg3 from
ginsenoside Rb1 is heat at 180◦ C for 30 min (Popovich and Kitts,
2004; Vo et al., 2015). Therefore, this heat-produced Rg3, the
intermediate metabolite of red and black ginseng, contributes
to the red/black ginseng efficient benefits including anti-cancer
(Keum et al., 2000), vasculature-protective (Lee M.R. et al., 2011),
and anti-obesity. Currently, commercial use of Rh2 and Rg3
are produced by chemical (mild acidic conditions) (Han et al.,
1982) or biological deglycosylation (microorganisms or glycoside
hydrolases) (Bae S.H. et al., 2014) of the major protopanaxadioltype ginsenosides. BST204, a ginsenoside extract containing a
high concentration of Rh2 and Rg3 mixtures, was prepared from
crude ginseng with a ginsenoside-β-glucosidase combined with
acid hydrolysis (Bae S.H. et al., 2014). Recently, yeast cell factories
are created to produce Rh2 or Rg3 from simple sugars (Wang
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FIGURE 5 | Ginsenoside Rg3 dose-dependently reverses lipid accumulation, protein expressions of differentiation markers in HPAs. The cells stained
with Oil-red O on day 15 were dissolved in isopropanol and fat accumulation was measured by absorbance using Synergy H1 hybrid reader at 490 nm. Oil-Red O
representative images of lipid accumulation and the average bar graph were shown (A, 200× magnification); Protein expressions of PPAR-γ (B), C/EBP-α (C),
FABP4 (D), and FAS (E) were determined by western blotting and normalized to β-actin expression. The same membrane was stripped using a stripping buffer and
blocked and probed with a new primary antibody to detect the next specific protein. Changes by treatment were expressed as the percentage of DMSO control.
Data are expressed as mean ± SE, n = 3. A set of representative images and bar graph were shown. ∗ P < 0.05, ∗∗ P < 0.01 vs. DMSO control.
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FIGURE 6 | In vivo effects of dietary ginsenoside Rg3 intake. After 8-week dietary administration of Rg3 (0.1 mg/kg diet), the liver PPAR-γ (A) and C/EBP-α (B)
protein expression in mice was determined by western blotting and normalized to β-actin expression. The same membrane was stripped using a stripping buffer and
blocked and probed with a new primary antibody to detect the next specific protein. Body weight gain, food intake, fasting blood glucose, and hepatic antioxidant
were measured and are shown in Table 1. Data are expressed as mean ± SE, n = 12. A set of representative images and bar graph were shown. ∗ P < 0.05,
∗∗ P < 0.01 vs. standard diet (SD) control.
TABLE 1 | Measurements of mice.
Group

Body weight gain
(g/mouse)

Food intake
(g/mouse/day)

Fasting blood
glucose (mg/dL)

Liver glutathione
reductase (nmol/min/mg
protein)

Liver glutathione
S-transferase
(nmol/min/mg protein)

SD

21.58 ± 1.85

3.85 ± 0.30

160.13 ± 16.94

50.22 ± 3.77

1171.84 ± 53.31

Rg3

23.53 ± 1.65

3.87 ± 0.27

142.42 ± 11.16

30.99 ± 1.42∗∗

∗∗ P

800.20 ± 17.22∗∗

< 0.01.

no report that dietary individual Rg3 prevents obesity in animals.
In the present study, we did not observe significantly changes of
body weight, food intake, and fat pad by dietary intake of Rg3
(0.01%, w/w) in ob/ob mice. But we found that Rg3 significantly
reduced PPAR-γ and C/EBP-α protein expressions in liver, fasting
blood glucose and two major endogenous antioxidant molecules
GS and GST, indicating that Rg3 has the potential to fight obese, at
least in liver, the factory of energy metabolism and adipogenesis.
The low dosage (0.01%, w/w) of Rg3 may contribute to the
failure of weight gain and fat pad changes. Because of the
complexity of the in vivo physiological environment, responses
to treatments in pre-adipocytes in vivo may differ from those
in 3T3-L1 and HPA cells. Although we are not sure, ob/ob
mice with normal diet may be not as efficient as the high-fatinduced obese mice in this kind of studies. In addition, there
is no clinical anti-obesity Rg3 report to our knowledge. In the
future human anti-obesity studies, we recommend to apply Rg3
to persons at the first year of life and prepuberty, which is
based on the fact that fat cells number increase is highest during
these ages (van Harmelen et al., 2003) and the inhibitory effect
in pre-adipocytes differentiation of Rg3 as we discussed in this
study. All these issues should be further addressed in the future
studies.

without a clonal expansion phase (Entenmann and Hauner,
1996). These differences may contribute to the different
sensitivity of compounds in inhibiting differentiation in our
study that minimum 30 µM of Rg3 was required in 3T3-L1
cells, but only 10 µM of Rg3 can significantly reduced fat
accumulation and relevant proteins in HPAs. This observation
is in line with a recent study that combined genistein, quercetin,
and resveratrol synergistically inhibited human pre-adipocytes
differentiation at lower levels than that in 3T3-L1 cells. Moreover,
3T3-L1 cells and HPAs react different in the apoptosis regulation
study (Papineau et al., 2003). In addition, this effective Rg3
concentration (10 µM) can be reached (10.2 µM) in 2 h after
oral ginsenoside Rg3 (50 mg/kg) in normal rats (Fan et al.,
2016), indicating that this Rg3 anti-obesity effect can apply to
humans with Rg3 supplements. Thus, this lower concentration
requirement in HPAs further supports our hypothesis that Rg3
might be an agent to prevent/reduce obesity in humans.
Red ginseng crude extract has been reported in preventing
obesity in rodent models by reducing leptin level and
adipogenesis level (Lee et al., 2010; Lee S.H. et al., 2012; Song
et al., 2012) as well as enhancing fatty acid oxidation and energy
expenditures via activation of PPAR-α in rats (200 mg/kg to
10 week-old, for 32 weeks) (Lee et al., 2007). However, there is
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Taken together, we found that Rg3 dose-dependently inhibited
cell differentiation, and expressions of adipogenic markers
including PPAR-γ, C/EBP-α, FAS, and perilipin in 3T3-L1 cells.
We are the first found that ginsenoside Rg3 inhibited preadipocyte differentiation in HPAs at much lower concentrations
compared to the concentrations required in rodent preadipocytes 3T3-L1 cells. We are also the first reporter that dietary
supplementation Rg3 attenuated hepatic protein expressions of
PPAR-γ and C/EBP-α, key regulators of adipogenesis and fat
metabolism, as well as the improvements in fasting blood glucose
and hepatic antioxidants GR and GST in obese mice. These
results suggest that ginsenoside Rg3 may be a potential agent in
reducing/preventing obesity.
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